Skip to main content
. 2016 Jun 20;9:3661–3669. doi: 10.2147/OTT.S96427

Figure 3.

Figure 3

Comparison of the partial remission rates in refractory AML (A) and middle-and-high-risk MDS (B) patients administered new and conventional priming regimens.

Abbreviations: PR, partial remission; AML, acute myeloid leukemia; MDS, myelodysplastic syndrome.